The Biomedical Excellence for Safer Transfusion (BEST) Collaborative is an international research organization dedicated to improving the safety of transfusion and cell therapy through standardized analytic techniques, innovative procedures, and clinical trials. To date, our work has resulted in more than 180 scientific publications.
Every four years, BEST renews its Board of Directors and scientific membership. Our President-Elect, Dr. Denese Marks (succeeding Dr. Rebecca Cardigan), will begin her term following the Fall 2026 meeting.
We are now looking for new talent to bring continued scientific vigor and fresh ideas to our team. Members are expected to actively participate in BEST studies, contribute innovative research ideas, and attend our interactive twice-yearly meetings, which alternate between North America in the autumn and Europe in the spring. To support these responsibilities, members will receive a stipend to help offset travel expenses.
Final Extended Application Deadline: Monday, August 10th, 2026
Decisions Announced: September 2026
First Teleconference: January 2027
First In-person Meeting: Spring 2027
New Procedure: If you have not already submitted an application, please fill out the application form in the link below and then send your CV and Application Letter to ernest.ho@bestcollaborative.org.
Step 1: Complete Application Form
Step 2: Submit CV and Application Letter
